Although the exact function of this protein is unknown, some studies suggested that decreased OLFM1 expression is associated with tumorigenesis, increased malignant potential, and worse progression-free survival and OS in colorectal cancer, endometrial cancer, and thyroid carcinoma (27–29). Here, OLFM1 is linked to endometrial cancer.